Q3 2025 · 13F-HR
GENERAL ATLANTIC, L.P.holdings as filed
Filed 2025-11-13 · accession 0000950142-25-002960
$3.33B
Reported value
16
Positions
2025-09-30
Period end
The Brief · GENERAL ATLANTIC, L.P. · Q3 2025
AI · grounded in 13F
GENERAL ATLANTIC, L.P. established a new position in DLO valued at $666.3M. The fund also initiated new stakes in XP for $479.5M and ALHC for $423.8M. Additional new positions include CHYM at $387.4M and ALKT at $297.9M. The fund ended the period with 16 positions and total AUM of $3.3B.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G29018101 | DLO | DLOCAL | $666.3M | 20.0% | 46,656,695 | Common | SOLE |
| G98239109 | XP | XP, INC | $479.5M | 14.4% | 25,517,733 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $423.8M | 12.7% | 24,287,227 | Common | SOLE |
| 16935C109 | CHYM | CHIME | $387.4M | 11.6% | 19,208,760 | Common | SOLE |
| 01644J108 | ALKT | ALKAMI | $297.9M | 8.94% | 11,991,480 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS | $272.2M | 8.17% | 5,733,989 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $234.8M | 7.05% | 9,681,818 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS | $200.4M | 6.02% | 8,031,252 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES | $115.6M | 3.47% | 2,474,428 | Common | SOLE |
| G9572D103 | BULL | WEBULL | $106.5M | 3.20% | 7,198,867 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA | $52.9M | 1.59% | 1,500,000 | Common | SOLE |
| 29882P106 | EWCZ | EUROPEAN WAX CENTER | $52.3M | 1.57% | 13,110,492 | Common | SOLE |
| M8216R109 | RSKD | RISKIFIED | $24.9M | 0.75% | 5,324,998 | Common | SOLE |
| 005329107 | ADAG | ADAGENE | $7.5M | 0.23% | 3,782,339 | Common | SOLE |
| 022307102 | ALMS | ALUMIS | $5.2M | 0.16% | 1,297,530 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE | $3.7M | 0.11% | 2,474,859 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.